2023 Q2 Form 10-K Financial Statement

#000121390023030833 Filed on April 19, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $699.4K $800.0K $4.796M
YoY Change -56.99% -43.07% 11.55%
Cost Of Revenue $437.6K $1.340M $6.109M
YoY Change -75.61% 17.62% 15.27%
Gross Profit $261.8K -$540.0K -$1.313M
YoY Change -255.34% -302.98% 31.23%
Gross Profit Margin 37.43% -67.5% -27.37%
Selling, General & Admin $1.649M $4.030M $14.43M
YoY Change -69.79% -63.65% -52.46%
% of Gross Profit 630.06%
Research & Development $46.30K $270.0K $951.4K
YoY Change -79.38% -1.86% -3.27%
% of Gross Profit 17.69%
Depreciation & Amortization $60.00K $150.0K $586.1K
YoY Change -57.76% -25.93% 47.47%
% of Gross Profit 22.92%
Operating Expenses $2.974M $4.290M $27.72M
YoY Change -61.99% -62.24% -11.54%
Operating Profit -$2.713M -$4.830M -$29.03M
YoY Change -66.06% -56.47% -10.21%
Interest Expense $93.98K -$110.0K $821.1K
YoY Change 361.6% 108.25% -152.33%
% of Operating Profit
Other Income/Expense, Net -$1.710M -$2.400M -$4.930M
YoY Change 166.8% 595.13% 56.18%
Pretax Income -$4.466M -$10.56M -$35.68M
YoY Change -48.7% -15.2% -4.56%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.450M -$12.38M -$32.29M
YoY Change -46.62% 0.73% -13.41%
Net Earnings / Revenue -636.35% -1547.5% -673.27%
Basic Earnings Per Share -$0.12 -$1.66
Diluted Earnings Per Share -$0.12 -$0.42 -$1.60
COMMON SHARES
Basic Shares Outstanding 86.47M shares 29.07M shares 22.04M shares
Diluted Shares Outstanding 22.04M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K $710.0K $710.0K
YoY Change -93.77% -81.29% -81.29%
Cash & Equivalents $104.2K $706.2K
Short-Term Investments
Other Short-Term Assets $2.210M $2.973M $130.0K
YoY Change -45.47% -25.04% -45.07%
Inventory $170.4K $405.0K $400.0K
Prepaid Expenses
Receivables $67.57K $239.4K $240.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $710.4K $1.479M $1.480M
YoY Change -72.69% -66.95% -66.93%
LONG-TERM ASSETS
Property, Plant & Equipment $179.3K $212.5K $2.270M
YoY Change -28.56% 106.48% 1770.01%
Goodwill $46.46K $46.46K
YoY Change -96.64% -96.62%
Intangibles $191.3K $230.1K
YoY Change -92.43% -90.54%
Long-Term Investments $870.0K $800.0K $800.0K
YoY Change -25.6% 4.04% 4.04%
Other Assets
YoY Change
Total Long-Term Assets $3.218M $3.341M $3.340M
YoY Change -57.25% -28.89% -28.91%
TOTAL ASSETS
Total Short-Term Assets $710.4K $1.479M $1.480M
Total Long-Term Assets $3.218M $3.341M $3.340M
Total Assets $3.929M $4.820M $4.820M
YoY Change -61.21% -47.46% -47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.60M $7.570M $7.570M
YoY Change 157.19% 102.92% 102.92%
Accrued Expenses $0.00 $330.0K $330.0K
YoY Change -100.0% 1688.62% 1688.62%
Deferred Revenue
YoY Change
Short-Term Debt $1.474M $1.684M $0.00
YoY Change -22.22% 25.4%
Long-Term Debt Due $1.474M $1.646M $7.020M
YoY Change -64.52% 14.45% 388.22%
Total Short-Term Liabilities $20.73M $15.21M $15.21M
YoY Change 118.31% 180.53% 180.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $40.00K $40.00K
YoY Change -100.0% -37.49% -37.49%
Other Long-Term Liabilities $2.240M $2.080M $2.080M
YoY Change 6.63%
Total Long-Term Liabilities $2.241M $2.116M $2.120M
YoY Change 5.08% 3206.09% 3213.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.73M $15.21M $15.21M
Total Long-Term Liabilities $2.241M $2.116M $2.120M
Total Liabilities $22.97M $17.32M $16.57M
YoY Change 97.55% 215.82% 124.95%
SHAREHOLDERS EQUITY
Retained Earnings -$179.0M -$146.1M
YoY Change 43.99% 33.3%
Common Stock $103.0K $39.06K
YoY Change 408.66% 134.03%
Preferred Stock
YoY Change
Treasury Stock (at cost) $78.46K
YoY Change 25.72%
Treasury Stock Shares 93.37K shares
Shareholders Equity -$19.92M -$11.75M -$11.75M
YoY Change
Total Liabilities & Shareholders Equity $3.929M $4.820M $4.820M
YoY Change -61.21% -47.46% -47.46%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$4.450M -$12.38M -$32.29M
YoY Change -46.62% 0.73% -13.41%
Depreciation, Depletion And Amortization $60.00K $150.0K $586.1K
YoY Change -57.76% -25.93% 47.47%
Cash From Operating Activities -$330.0K -$2.950M -$16.81M
YoY Change -94.09% -39.82% -18.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $210.0K $212.2K
YoY Change -100.0% -800.7% -298.03%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.090M $1.000M
YoY Change -100.0% 482.92% -194.26%
Cash From Investing Activities $0.00 $860.0K $373.2K
YoY Change -100.0% 447.63% -131.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$5.706M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 270.0K 2.350M $13.41M
YoY Change -93.65% -66.69% -23.9%
NET CHANGE
Cash From Operating Activities -330.0K -2.950M -$16.81M
Cash From Investing Activities 0.000 860.0K $373.2K
Cash From Financing Activities 270.0K 2.350M $13.41M
Net Change In Cash -60.00K 260.0K -$3.089M
YoY Change -96.36% -88.75% -24.13%
FREE CASH FLOW
Cash From Operating Activities -$330.0K -$2.950M -$16.81M
Capital Expenditures $0.00 $210.0K $212.2K
Free Cash Flow -$330.0K -$3.160M -$17.02M
YoY Change -93.79% -35.14% -16.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 crtd Derivative Expense
DerivativeExpense
usd
CY2022 us-gaap Dividend Income Operating
DividendIncomeOperating
usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
usd
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 crtd Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
CY2021 crtd Weighted Average Remaining Contractual Lifein Years Forfeited Cancelled
WeightedAverageRemainingContractualLifeinYearsForfeitedCancelled
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86469195 shares
CY2022Q2 dei Entity Public Float
EntityPublicFloat
14213436 usd
CY2022 dei Auditor Name
AuditorName
Rosenberg Rich Baker Berman, P.A.
CY2022 dei Auditor Location
AuditorLocation
Somerset, New Jersey
CY2022 crtd Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
706224 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3794734 usd
CY2022 crtd Weighted Average Remaining Contractual Lifein Years Forfeited Cancelled
WeightedAverageRemainingContractualLifeinYearsForfeitedCancelled
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
239423 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
337440 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
404970 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
106403 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
128547 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236665 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1479164 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4475242 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
212545 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102939 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
230084 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2432841 usd
CY2022Q4 us-gaap Goodwill
Goodwill
46460 usd
CY2021Q4 us-gaap Goodwill
Goodwill
1374835 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
797231 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
718951 usd
CY2021Q4 crtd Minority Investment In Business
MinorityInvestmentInBusiness
50000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2054265 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18451 usd
CY2022Q4 us-gaap Assets
Assets
4819749 usd
CY2021Q4 us-gaap Assets
Assets
9173259 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7565720 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3730540 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
5369599 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
159193 usd
CY2022 dei City Area Code
CityAreaCode
(201)
CY2022 dei Local Phone Number
LocalPhoneNumber
258-3770
CY2022 dei Security12b Title
Security12bTitle
N/A
CY2022 dei Trading Symbol
TradingSymbol
N/A
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39500
CY2022 dei Entity Registrant Name
EntityRegistrantName
CREATD, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0645394
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
419 Lafayette Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
CY2022Q4 crtd Operating Lease Payable Long Term
OperatingLeasePayableLongTerm
326908 usd
CY2021Q4 crtd Operating Lease Payable Long Term
OperatingLeasePayableLongTerm
18451 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1645680 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1278672 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
299409 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
234159 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15207316 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5421015 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
38014 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
63992 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2077618 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2115632 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
63992 usd
CY2022Q4 us-gaap Liabilities
Liabilities
17322948 usd
CY2021Q4 us-gaap Liabilities
Liabilities
5485007 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39062386 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38969013 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16691170 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16685513 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
39062 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16691 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
134570600 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
111563618 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
93373 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5657 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
78456 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
62406 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146142373 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109632574 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140183 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78272 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11751350 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1807057 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-751849 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1881195 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-12503199 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3688252 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4819749 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9173259 usd
CY2022 us-gaap Revenues
Revenues
4796474 usd
CY2021 us-gaap Revenues
Revenues
4299717 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
6109206 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
5300037 usd
CY2022 us-gaap Gross Profit
GrossProfit
-1312732 usd
CY2021 us-gaap Gross Profit
GrossProfit
-1000320 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
4678390 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5812057 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
951414 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983528 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4700171 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9626982 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4183844 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
9661168 usd
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1433815 usd
CY2021 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1035795 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2043011 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
688127 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9727735 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4560743 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
27718380 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
32368400 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-29031112 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-33368720 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
99 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
396223 usd
CY2022 us-gaap Interest Expense
InterestExpense
821051 usd
CY2021 us-gaap Interest Expense
InterestExpense
372106 usd
CY2022 crtd Accretion Of Debt Discount And Issuance Cost
AccretionOfDebtDiscountAndIssuanceCost
4668039 usd
CY2021 crtd Accretion Of Debt Discount And Issuance Cost
AccretionOfDebtDiscountAndIssuanceCost
3612669 usd
CY2021 crtd Derivative Expense
DerivativeExpense
100502 usd
CY2022 crtd Change In Derivative Liability
ChangeInDerivativeLiability
3729 usd
CY2021 crtd Change In Derivative Liability
ChangeInDerivativeLiability
-1096287 usd
CY2022 crtd Impairment Of Investment
ImpairmentOfInvestment
-50000 usd
CY2021 crtd Impairment Of Investment
ImpairmentOfInvestment
-589461 usd
CY2022 crtd Settlement Of Vendor Liabilities
SettlementOfVendorLiabilities
-265717 usd
CY2021 crtd Settlement Of Vendor Liabilities
SettlementOfVendorLiabilities
59692 usd
CY2022 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-11742 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-832482 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1025655 usd
CY2021 crtd Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
279022 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-6645203 usd
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-4010433 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35676315 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37379153 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-35676315 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-37379153 usd
CY2022 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-3383044 usd
CY2021 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-86251 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32293271 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-37292902 usd
CY2022 crtd Deemed Dividends
DeemedDividends
-4216528 usd
CY2021 crtd Deemed Dividends
DeemedDividends
-410750 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36509799 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37703652 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-35676315 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-37379153 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61911 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41038 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35738226 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37420191 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.98
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22035260 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12652470 shares
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5445196 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9447075 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
226500 usd
CY2021 crtd Stock Issued During Period Value Common Stock Issued To Settle Vendor Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedToSettleVendorLiabilities
791386 usd
CY2021 crtd Common Stock Issued Upon Conversion Of Notes Payable
CommonStockIssuedUponConversionOfNotesPayable
5156994 usd
CY2021 crtd Exercise Of Warrants To Stock
ExerciseOfWarrantsToStock
9487223 usd
CY2021 crtd Cash Received For Common Stock And Warrants
CashReceivedForCommonStockAndWarrants
5666950 usd
CY2021 crtd Cash Received For Preferred Series E And Warrants
CashReceivedForPreferredSeriesEAndWarrants
35775 usd
CY2021 crtd Stock Warrants Issued With Note Payable
StockWarrantsIssuedWithNotePayable
1665682 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3185662 usd
CY2021 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-41038 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-37379153 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3688252 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4087404 usd
CY2022 crtd Stock Issued During Period Value Common Stock Issued To Settle Vendor Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedToSettleVendorLiabilities
410499 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
141150 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
40995 usd
CY2022 crtd Bcf Issued With Note Payable
BCFIssuedWithNotePayable
2008227 usd
CY2022 crtd Exercise Of Warrants To Stock
ExerciseOfWarrantsToStock
1781947 usd
CY2022 crtd Purchase Of Treasury Stock And Warrants
PurchaseOfTreasuryStockAndWarrants
16050 usd
CY2022 crtd Stock Warrants Issued With Note Payable
StockWarrantsIssuedWithNotePayable
3149270 usd
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
190000 usd
CY2022 crtd Cash Received For Common Stock And Warrants
CashReceivedForCommonStockAndWarrants
5722300 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
409945 usd
CY2022 crtd Common Stock Issued Upon Conversion Of Notes Payable
CommonStockIssuedUponConversionOfNotesPayable
1061088 usd
CY2022 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-61911 usd
CY2022 crtd Sale Of Minority Interest In Og Collection Inc
SaleOfMinorityInterestInOGCollectionINC
750000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-35676315 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-12503199 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-35676315 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-37379153 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
586109 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
397440 usd
CY2022 crtd Impairment Of Investment
ImpairmentOfInvestment
-50000 usd
CY2021 crtd Impairment Of Investment
ImpairmentOfInvestment
-589461 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1433815 usd
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1038905 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2043011 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
688127 usd
CY2022 crtd Otherimpairmentof Rou
OtherimpairmentofROU
101623 usd
CY2022 crtd Accretion Of Debt Discount And Issuance Costs
AccretionOfDebtDiscountAndIssuanceCosts
4668039 usd
CY2021 crtd Accretion Of Debt Discount And Issuance Costs
AccretionOfDebtDiscountAndIssuanceCosts
3612669 usd
CY2022 crtd Sharebased In Compensation
SharebasedInCompensation
4183844 usd
CY2021 crtd Sharebased In Compensation
SharebasedInCompensation
9661174 usd
CY2022 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
40994 usd
CY2022 crtd Bad Debt Expense
BadDebtExpense
398130 usd
CY2021 crtd Bad Debt Expense
BadDebtExpense
110805 usd
CY2022 crtd Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
-832482 usd
CY2021 crtd Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
1304677 usd
CY2022 crtd Vendor Debt
VendorDebt
-265717 usd
CY2021 crtd Vendor Debt
VendorDebt
59692 usd
CY2022 crtd Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
3729 usd
CY2021 crtd Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-1096287 usd
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
100502 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-11742 usd
CY2022 crtd Non Cash Lease Expense
NonCashLeaseExpense
274784 usd
CY2021 crtd Non Cash Lease Expense
NonCashLeaseExpense
82511 usd
CY2022 crtd Reserve For Obsolete Inventory
ReserveForObsoleteInventory
-399058 usd
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-123710 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-16413 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-86155 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
174819 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
479356 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39182 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
755907 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
80407 usd
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
78280 usd
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
527115 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
65250 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
144851 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4773551 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1714902 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-26146 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-84099 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16805429 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20518807 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
212249 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95935 usd
CY2021 crtd Cash Paid For Minority Investment In Business
CashPaidForMinorityInvestmentInBusiness
325000 usd
CY2021 crtd Cash Paid For Equity Method Investment
CashPaidForEquityMethodInvestment
510000 usd
CY2022 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
48878 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
37135 usd
CY2022 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
750000 usd
CY2022 crtd Cash Consideration For Acquisition
CashConsiderationForAcquisition
31679 usd
CY2021 crtd Cash Consideration For Acquisition
CashConsiderationForAcquisition
225947 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
410369 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11241 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
289246 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
373206 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1168123 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1781947 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9487223 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
2219219 usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
747937 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2830382 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
456233 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
8391905 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3610491 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1863315 usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
941880 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
538574 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5722300 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5666951 usd
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
40000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16050 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13405624 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17615915 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-61911 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-41038 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3088510 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4112053 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3794734 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7906787 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
706224 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3794734 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
650000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
60073 usd
CY2021 crtd Settlement Of Vendor Liabilities Reduction Of Rou Asset Related To Remeasurement Of Lease Liability
SettlementOfVendorLiabilitiesReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability
168667 usd
CY2022 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
2008227 usd
CY2022 crtd Warrants Issued With Debt
WarrantsIssuedWithDebt
3149270 usd
CY2021 crtd Warrants Issued With Debt
WarrantsIssuedWithDebt
1665682 usd
CY2022 crtd Shares Issued With Debt
SharesIssuedWithDebt
409945 usd
CY2022 crtd Share Issued For Acquisition
ShareIssuedForAcquisition
141150 usd
CY2021 crtd Share Issued For Acquisition
ShareIssuedForAcquisition
226500 usd
CY2022 crtd Operating Lease Liability1
OperatingLeaseLiability1
2412221 usd
CY2021 crtd Deferred Offering Cost
DeferredOfferingCost
4225 usd
CY2022 crtd Common Stock And Warrants Issued Upon Conversion Of Notes Payable
CommonStockAndWarrantsIssuedUponConversionOfNotesPayable
1061088 usd
CY2021 crtd Common Stock And Warrants Issued Upon Conversion Of Notes Payable
CommonStockAndWarrantsIssuedUponConversionOfNotesPayable
5156994 usd
CY2021 crtd Shares Issued For Acquisition
SharesIssuedForAcquisition
1318218 usd
CY2021 crtd Reduction Of Rou Asset Related To Remeasurement Of Lease Liability
ReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability
135086 usd
CY2021 crtd Repayment Of Promissory Notes From Australian Rd Credits
RepaymentOfPromissoryNotesFromAustralianRDCredits
146630 usd
CY2022Q4 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
150000 shares
CY2022Q4 crtd Purchase Price
PurchasePrice
750000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Use of Estimates and Critical Accounting Estimates and Assumptions</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful accounts, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, and impairment of intellectual property.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
18964 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
76313 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
207301 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2022 crtd All Other Expenses
AllOtherExpenses
11742 usd
CY2021 crtd All Other Expenses
AllOtherExpenses
0 usd
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
2432841 usd
CY2021Q4 us-gaap Goodwill
Goodwill
1374835 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
230084 usd
CY2022Q4 us-gaap Goodwill
Goodwill
46460 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
276544 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22783 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
230084 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
483484 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
308474 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Concentration of Credit Risk and Other Risks and Uncertainties</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides credit in the normal course of business. The Company maintains allowances for credit losses on factors surrounding the credit risk of specific customers, historical trends, and other information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in Australia and holds total assets of $700,268. It is reasonably possible that operations located outside an entity’s home country will be disrupted in the near term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
700268 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2043111 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
688127 usd
CY2022 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
32097 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
32098 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
28863 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
18966 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
348186 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1433815 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1035795 usd
CY2022 crtd Investment Term
InvestmentTerm
P2Y
CY2022 crtd Weighted Average Maturity Term
WeightedAverageMaturityTerm
P1Y
CY2021 us-gaap Impairment Of Investments
ImpairmentOfInvestments
62733 usd
CY2022 crtd Impairment Of Equity Security
ImpairmentOfEquitySecurity
50000 usd
CY2021 crtd Impairment Of Equity Security
ImpairmentOfEquitySecurity
102096 usd
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
299409 usd
CY2022 us-gaap Revenues
Revenues
4796474 usd
CY2021 us-gaap Revenues
Revenues
4299717 usd
CY2022 crtd Products And Services Transferred Over Time
ProductsAndServicesTransferredOverTime
3331741 usd
CY2021 crtd Products And Services Transferred Over Time
ProductsAndServicesTransferredOverTime
4182681 usd
CY2022 crtd Products Transferred At A Point In Time
ProductsTransferredAtAPointInTime
1464733 usd
CY2021 crtd Products Transferred At A Point In Time
ProductsTransferredAtAPointInTime
117036 usd
CY2022 us-gaap Revenues
Revenues
4796474 usd
CY2021 us-gaap Revenues
Revenues
4299717 usd
CY2022 crtd Management Fee Percentage
ManagementFeePercentage
0.20 pure
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.80 pure
CY2022 crtd Contract Occur Percentage
ContractOccurPercentage
1 pure
CY2022 crtd Promotional Discounts Amount
PromotionalDiscountsAmount
9.99 usd
CY2022 crtd Free Trials Amount
FreeTrialsAmount
99 usd
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
234159 usd
CY2022 crtd Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
585077 usd
CY2021 crtd Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
186147 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
399.058 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022 crtd Product Obsolescence
ProductObsolescence
399058 usd
CY2021 crtd Product Obsolescence
ProductObsolescence
0 usd
CY2022 crtd Net Income Loss Amount
NetIncomeLossAmount
35700000 usd
CY2022 crtd Net Cash Used In Operating Activities Going Concern
NetCashUsedInOperatingActivitiesGoingConcern
16700000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
1426728 usd
CY2022 crtd Common Stock Equivalents
CommonStockEquivalents
47255939 shares
CY2021 crtd Common Stock Equivalents
CommonStockEquivalents
8682808 shares
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Reclassifications</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year’s presentation. These reclassifications did not affect the prior period’s total assets, total liabilities, stockholders’ deficit, net loss or net cash used in operating activities. During the year ended December 31, 2021, we adopted a change in presentation on our consolidated statements of operations and comprehensive loss in order to present a gross profit line, the presentation of which is consistent with our peers. Under the new presentation, we began allocating payroll and related expenses, professional services and creator payouts. Prior periods have been revised to reflect this change in presentation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 crtd Deemed Dividend
DeemedDividend
3187906 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2000000 usd
CY2022 crtd Accumulated Deficit Net Loss
AccumulatedDeficitNetLoss
146200000 usd
CY2022Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
34632 usd
CY2021Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2907 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
370335 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
103496 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
404970 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
106403 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
680000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
467753 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
467455 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
364814 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
212545 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
102939 usd
CY2022 us-gaap Depreciation
Depreciation
102643 usd
CY2021 us-gaap Depreciation
Depreciation
49254 usd
CY2021Q3 us-gaap Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
10%
CY2022Q2 us-gaap Other Notes Payable
OtherNotesPayable
104500 usd
CY2022Q2 crtd Vendor Liabilities
VendorLiabilities
104500 usd
CY2022Q3 us-gaap Secured Debt Other
SecuredDebtOther
134070 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
6810992 usd
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
168850 usd
CY2022Q4 crtd Outstanding Principal Total
OutstandingPrincipalTotal
1683694 usd
CY2021Q4 crtd Outstanding Principal Total
OutstandingPrincipalTotal
1358211 usd
CY2022 crtd Less Debt Discount
LessDebtDiscount
314108 usd
CY2021 crtd Less Debt Discount
LessDebtDiscount
15547 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1683694 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1342664 usd
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
1645680 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
1278672 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
38014 usd
CY2021Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
63992 usd
CY2021Q4 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
1637 usd
CY2021 us-gaap-sup Debt Instrument Repaid Principal
DebtInstrumentRepaidPrincipal
83855 usd
CY2022Q4 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
10850 usd
CY2022 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
5000 usd
CY2020Q2 us-gaap Principal Amount Outstanding On Loans Managed And Securitized
PrincipalAmountOutstandingOnLoansManagedAndSecuritized
412500 usd
CY2022Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.01 pure
CY2021 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
275903 usd
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
3119 usd
CY2020Q4 us-gaap Secured Debt Other
SecuredDebtOther
74300 aud
CY2020Q4 us-gaap Secured Debt Other
SecuredDebtOther
54412 usd
CY2020Q4 us-gaap Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
14%
CY2021Q4 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
4850 aud
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
6408 usd
CY2020Q4 us-gaap Notes Issued1
NotesIssued1
34000 usd
CY2020Q4 us-gaap Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
14%
CY2020 us-gaap-sup Debt Instrument Repaid Principal
DebtInstrumentRepaidPrincipal
10284 usd
CY2021Q1 us-gaap Secured Debt Other
SecuredDebtOther
111683 aud
CY2021Q1 us-gaap Secured Debt Other
SecuredDebtOther
81789 usd
CY2021Q1 us-gaap Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
14%
CY2021Q2 us-gaap Notes Issued1
NotesIssued1
128110 usd
CY2021Q2 us-gaap Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
11%
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
35970 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
8341 usd
CY2021Q3 us-gaap Notes Issued1
NotesIssued1
137625 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
8120 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
14665 usd
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1537 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5369599 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
159193 usd
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
230162 usd
CY2022 crtd Remaining Balance
RemainingBalance
866650 usd
CY2022 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
562500 shares
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
80000 usd
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party Noncurrent
RelatedPartyTransactionDueFromToRelatedPartyNoncurrent
484753 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
277000 shares
CY2022Q4 crtd Common Stock Shares
CommonStockShares
272000 shares
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
172091 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
138713 usd
CY2022 crtd Expected Dividend Yield Percentage
ExpectedDividendYieldPercentage
0 pure
CY2022Q4 crtd Shares Of Capital Stock
SharesOfCapitalStock
1520000000 shares
CY2022Q4 crtd Designated Of Common Stock Shares
DesignatedOfCommonStockShares
-1500000000 shares
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q4 crtd Designated Of Preferred Stock
DesignatedOfPreferredStock
-20000000 shares
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2021Q4 us-gaap Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable
PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable
40000 usd
CY2021 crtd Stock Issuance Cost
StockIssuanceCost
4225 usd
CY2021Q1 crtd Stock Issued Period For Service
StockIssuedPeriodForService
192000 usd
CY2021Q2 crtd Additional Restricted Common Stock
AdditionalRestrictedCommonStock
10000 shares
CY2021Q2 crtd Fair Value Amount
FairValueAmount
34500 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
99908 usd
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
10000 shares
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
43667 usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
12719 usd
CY2021Q2 crtd Share Of Common Stock
ShareOfCommonStock
1048 shares
CY2021Q2 crtd Stock Issued Period For Service
StockIssuedPeriodForService
3587 usd
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
87716 shares
CY2022 crtd Shares Of Common Stock
SharesOfCommonStock
16050 shares
CY2022 crtd Option Exercisable Number Exercisable
OptionExercisableNumberExercisable
3061767 shares
CY2021Q2 crtd Underwriting Agreement Description
UnderwritingAgreementDescription
the Company entered into an underwriting agreement with The Benchmark Company LLC, pursuant to which we agreed to sell to the Underwriter in a firm commitment underwritten public offering an aggregate of 750,000 shares of the Company’s common stock, at a public offering price of $3.40 per share. The Company also granted the Underwriter a 30-day option to purchase up to an additional 112,500 shares of Common Stock to cover over-allotments, if any. The Offering closed on June 21, 2021. The net proceeds to the Company from the equity raise was $2,213,500. As part of the underwriting agreement the Company issued 46,667 warrants of the Company’s common stock to Benchmark. The warrants have an exercise price $5.40 and a term of five years. On July 9, 2021, the Representative exercised the over-allotment option to purchase an additional 954,568 shares of Common Stock.
CY2021Q4 crtd Securities Purchase Agreement Description
SecuritiesPurchaseAgreementDescription
the Company entered into a securities purchase agreement with institutional investors resulting in the raise of $3,407,250 in gross proceeds to the Company. Pursuant to the terms of the purchase agreement, the Company agreed to sell, in a registered direct offering, an aggregate of 850,000 shares of the Company’s common stock, par value $0.001 per share, at a purchase price of $4.50 per Share.
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
25000 shares
CY2021Q4 crtd Stock Issued Period For Service
StockIssuedPeriodForService
85750 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
13392 shares
CY2021Q4 crtd Stock Issued Period For Service
StockIssuedPeriodForService
41917 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
250000 shares
CY2021Q4 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
576783 usd
CY2021Q4 crtd Settlement Of Vendor Liabilities
SettlementOfVendorLiabilities
33217 usd
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
101097 shares
CY2021Q4 crtd Restricted Common Stock
RestrictedCommonStock
246676 shares
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
194 shares
CY2021Q4 crtd Restricted Common Stock
RestrictedCommonStock
429 shares
CY2021Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
211 shares
CY2021Q4 crtd Restricted Common Stock
RestrictedCommonStock
452 shares
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
307342 shares
CY2022 crtd Vendor Liabilities
VendorLiabilities
265717 usd
crtd Accrued But Unpaid
AccruedButUnpaid
69000 usd
CY2022Q1 crtd Gross Proceeds
GrossProceeds
2659750 usd
CY2022Q1 crtd Aggregate Common Stock Shares
AggregateCommonStockShares
1519857 shares
CY2022Q1 crtd Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
1519857 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.75
CY2022 crtd Stock Issuance Costs
StockIssuanceCosts
75000 usd
CY2022Q1 crtd Stock Issued Period For Service
StockIssuedPeriodForService
7488 usd
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
8364 usd
CY2022Q2 crtd Restricted Common Stock
RestrictedCommonStock
185000 shares
CY2022Q2 crtd Stock Issued Period For Service
StockIssuedPeriodForService
192400 usd
CY2022Q2 crtd Restricted Common Stock
RestrictedCommonStock
50000 shares
CY2022Q2 crtd Stock Issued Period For Service
StockIssuedPeriodForService
37200 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2405 usd
CY2022Q2 crtd Stock Issued Period For Service
StockIssuedPeriodForService
29387 usd
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
24001 usd
CY2022Q3 crtd Gross Proceeds
GrossProceeds
796000 usd
CY2022Q3 crtd Aggregate Common Stock Shares
AggregateCommonStockShares
4000000 shares
CY2022Q3 crtd Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
4000000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.2
CY2022Q3 crtd Stock Issuance Costs
StockIssuanceCosts
75000 usd
CY2022Q4 crtd Fair Value
FairValue
111324 usd
CY2022Q4 crtd Restricted Common Stock
RestrictedCommonStock
44894 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
541021 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.75
CY2021 crtd Weighted Average Remaining Contractual Lifein Years Beginning Balance
WeightedAverageRemainingContractualLifeinYearsBeginningBalance
P3Y3M7D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2425762 shares
CY2021 crtd Weighted Average Exercise Price Granted
WeightedAverageExercisePriceGranted
5.97
CY2021 crtd Share Based Compensation Award Options Weighted Average Remaining Contractual Life Granted
ShareBasedCompensationAwardOptionsWeightedAverageRemainingContractualLifeGranted
P5Y10M28D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
64164 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.06
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2902619 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2021 crtd Weighted Average Remaining Contractual Lifein Years Outstanding Ending Balance
WeightedAverageRemainingContractualLifeinYearsOutstandingEndingBalance
P4Y8M15D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1940000 shares
CY2022 crtd Weighted Average Exercise Price Granted
WeightedAverageExercisePriceGranted
1.38
CY2022 crtd Share Based Compensation Award Options Weighted Average Remaining Contractual Life Granted
ShareBasedCompensationAwardOptionsWeightedAverageRemainingContractualLifeGranted
P5Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
434352 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.56
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4408267 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.05
CY2022 crtd Weighted Average Remaining Contractual Lifein Years Outstanding Ending Balance
WeightedAverageRemainingContractualLifeinYearsOutstandingEndingBalance
P4Y3M14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3061767 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.19
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y25D
CY2022 crtd Option Outstanding Exercise Price
OptionOutstandingExercisePrice
4.05
CY2022 crtd Option Outstanding Number Outstanding
OptionOutstandingNumberOutstanding
4408267 shares
CY2022 crtd Option Outstanding Weighted Average Remaining Contractual Lifein Years
OptionOutstandingWeightedAverageRemainingContractualLifeinYears
P4Y3M14D
CY2022 crtd Option Exercisable Weighted Average Exercise Price
OptionExercisableWeightedAverageExercisePrice
4.19
CY2022 crtd Option Exercisable Weighted Average Remaining Contractual Lifein Years
OptionExercisableWeightedAverageRemainingContractualLifeinYears
P4Y25D
CY2021Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
7616195 usd
CY2022 crtd Unvested Employee Options Description
UnvestedEmployeeOptionsDescription
As of December 31, 2022, there was $237,522 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 0.14 years. 
CY2021Q4 crtd Shares Issued1
SharesIssued1
2250691 shares
CY2021 crtd Warrant Holder Shares
WarrantHolderShares
2414218 shares
CY2021 crtd Proceed From Warrant Exercises
ProceedFromWarrantExercises
9487223 usd
CY2021 crtd Total Warrant Issued
TotalWarrantIssued
1137575 shares
CY2021 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3258955 usd
CY2021 crtd Additional Warrant
AdditionalWarrant
127801 shares
CY2021 us-gaap Dividends Cash
DividendsCash
410750 usd
CY2021 crtd Underwriting Agreement
UnderwritingAgreement
80000 shares
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
480863 usd
CY2022 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
5246953
CY2022 us-gaap Dividends Cash
DividendsCash
4216528 usd
CY2022 crtd Warrant Issued With Debt
WarrantIssuedWithDebt
6712500 shares
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3171076 usd
CY2022Q4 crtd Seeking Damages
SeekingDamages
161000 usd
CY2022Q4 crtd Punitive Damages
PunitiveDamages
500000 usd
CY2022Q4 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
161000 usd
CY2022Q1 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
920000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.15 pure
CY2022Q3 crtd Excise Tax On Net Repurchases Percentage
ExciseTaxOnNetRepurchasesPercentage
0.01 pure
CY2022 crtd Lease Agreements Description
LeaseAgreementsDescription
The Company currently does not own any properties. Our corporate headquarters consists of a total of 8,000 square feet and is located at 419 Lafayette Street, 6th Floor, New York, NY, 10003. The current lease term is 7 years commencing May 1, 2022. The total amount due under this lease is $3,502,033. On April 19, 2022, the Company signed a 2-year lease for approximately 2,252 square feet of office space at 1 Westmount Square, Westmount, Qc H3Z2P9. Commencement date of the lease is July 1, 2022. The total amount due under this lease is $72,064. During the year ended December 31, 2022, it was decided the company would not be using the office space and recorded an impairment of $63,472 on the right-of-use asset. As of December 31, 2022, the company was in breach of this lease agreement and subsequently reached a settlement agreement to terminate the lease. On July 28, 2022, the Company signed a 3-year lease for approximately 1,364 square feet of office space at 1674 Meridian Ave., Miami Beach, FL, 33131. Commencement date of the lease is July 28, 2022. The total amount due under this lease is $181,299. During the year ended December 31, 2022, it was decided the company would not be using the office space and recorded an impairment of $101,623 on the right-of-use asset. As of December 31, 2022, the company is in breach of this lease agreement. On September 9, 2021, the Company signed a 1-year lease for approximately 3,200 square feet at 648 Broadway, Suite 200, New York, NY 10012.
CY2022Q2 us-gaap Lease Income
LeaseIncome
3502033 usd
CY2022Q2 crtd Lease Agreements Description
LeaseAgreementsDescription
On April 19, 2022, the Company signed a 2-year lease for approximately 2,252 square feet of office space at 1 Westmount Square, Westmount, Qc H3Z2P9
CY2022Q2 us-gaap Lease Income
LeaseIncome
72064 usd
CY2022Q2 crtd Impaired Asset
ImpairedAsset
63472 usd
CY2022Q3 crtd Lease Agreements Description
LeaseAgreementsDescription
On July 28, 2022, the Company signed a 3-year lease for approximately 1,364 square feet of office space at 1674 Meridian Ave.
CY2022Q3 us-gaap Lease Income
LeaseIncome
181299 usd
CY2022Q4 crtd Impaired Asset
ImpairedAsset
101623 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
398498 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
139136 usd
CY2022 us-gaap Lease Cost
LeaseCost
537634 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
206944 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.125 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
583728 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
550705 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
517231 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
532424 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
548073 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
754064 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3486225 usd
CY2022Q4 crtd Less Amounts Representing Interest
LessAmountsRepresentingInterest
1081698 usd
CY2022Q4 crtd Total Lease Obligations
TotalLeaseObligations
2404526 usd
CY2022Q4 crtd Less Current Operating Lease
LessCurrentOperatingLease
326908 usd
CY2022Q4 crtd Operating Lease Liabilitys
OperatingLeaseLiabilitys
2077618 usd
CY2022 crtd Rent Expense
RentExpense
590100 usd
CY2021 crtd Rent Expense
RentExpense
216845 usd
CY2021Q1 crtd Stockholders Equity Requirement
StockholdersEquityRequirement
On September 2, 2022, the Company received a letter from the staff of The Nasdaq Capital Market notifying the Company that the Nasdaq Hearings Panel has determined to delist the Company’s common stock from the Exchange, based on the Company’s failure to comply with the listing requirements of Nasdaq Rule 5550(b)(1) as a result of the Company’s shareholder equity deficit for the period ended June 30, 2022, as demonstrated in Company’s Quarterly Report on Form 10-Q filed on August 15, 2022, following the Company having not complied with the market value of listed securities requirement in Nasdaq Rule 5550(b)(2) on March 1, 2022, while the Company was under a Panel Monitor, as had been previously disclosed.
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
475000 usd
CY2021Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
490863 shares
CY2021Q2 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.33 pure
CY2021Q2 us-gaap Memberships In Exchanges Owned
MembershipsInExchangesOwned
175000 usd
CY2021Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
841005 shares
CY2021Q2 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.89 pure
CY2021Q2 us-gaap Memberships In Exchanges Owned
MembershipsInExchangesOwned
300000 usd
CY2022 crtd Schedule Of Excess Purchase Price Amounts
ScheduleOfExcessPurchasePriceAmounts
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,198</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names &amp; Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">316,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Website</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,300</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">504,998</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,349,697</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names &amp; Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,945</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Non-Compete Agreements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,190</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Influencers / Customers</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">627,610</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,108,442</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">64,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names &amp; Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,304</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">858,300</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Website</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">127,864</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,258,698</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">12,691</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names &amp; Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,970</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,633</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,693</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">178,987</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">46,460</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names &amp; Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,705</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Website</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">106,596</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.44 pure
CY2021Q3 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
1038271 usd
CY2021Q3 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
224503 shares
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.98
CY2021Q3 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
1038271 usd
CY2021Q3 us-gaap Noncontrolling Interest In Variable Interest Entity
NoncontrollingInterestInVariableInterestEntity
1190000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
1349697 usd
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
85945 usd
CY2022Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
45190 usd
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
627610 usd
CY2021Q4 us-gaap Cost Method Investments
CostMethodInvestments
732297 usd
CY2021Q4 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
424632 usd
CY2021Q4 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
3905634 usd
CY2021Q4 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
163344 shares
CY2021Q4 us-gaap Repurchase Agreement Counterparty Amount At Risk
RepurchaseAgreementCounterpartyAmountAtRisk
50000 usd
CY2022Q1 crtd Purchase Price Per Share
PurchasePricePerShare
1
CY2022 crtd Repayment Of Promissory Notes From Australian Rd Credits
RepaymentOfPromissoryNotesFromAustralianRDCredits
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
239423 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
128547 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
797231 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
230084 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
46460 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
404970 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2973034 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
4819749 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7565720 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1683694 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
299409 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7774125 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
17322948 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
337440 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236665 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
718951 usd
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
2432841 usd
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
1374835 usd
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
106403 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3966124 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
9173259 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3730540 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1342664 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
234159 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
177644 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
5485007 usd
CY2022 us-gaap Revenues
Revenues
4796474 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
6109206 usd
CY2022 us-gaap Gross Profit
GrossProfit
-1312732 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4678390 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
951414 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4700171 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4183844 usd
CY2022 crtd General And Administrative
GeneralAndAdministrative
9024428 usd
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
592139 usd
CY2022 crtd Impairment Of Intangible Assets Excluding Goodwill1
ImpairmentOfIntangibleAssetsExcludingGoodwill1
3587994 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
27718380 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
821051 usd
CY2022 crtd All Other Expense
AllOtherExpense
5824152 usd
CY2022 crtd Other Expenses Net
OtherExpensesNet
-6645203 usd
CY2022 crtd Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments
LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments
-35676315 usd
CY2021 us-gaap Revenues
Revenues
4299717 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
5300037 usd
CY2021 us-gaap Gross Profit
GrossProfit
-1000320 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983528 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9626982 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
9661168 usd
CY2021 us-gaap Goodwill Impairment Loss Net Of Tax
GoodwillImpairmentLossNetOfTax
1035795 usd
CY2021 crtd General And Administrative
GeneralAndAdministrative
9975360 usd
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
397440 usd
CY2021 crtd Impairment Of Intangible Assets Excluding Goodwill1
ImpairmentOfIntangibleAssetsExcludingGoodwill1
688127 usd
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
32368400 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
372106 usd
CY2021 crtd All Other Expense
AllOtherExpense
3638327 usd
CY2021 crtd Other Expenses Net
OtherExpensesNet
-4010433 usd
CY2021 crtd Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments
LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments
-37379153 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
24850 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-876459 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5545450 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
20744537 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25388679 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.071 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.071 pure
CY2022 crtd Change In Valuation Allowance On Net Operating Loss Carryforwardsin Dollars
ChangeInValuationAllowanceOnNetOperatingLossCarryforwardsinDollars
-0.281 pure
CY2021 crtd Change In Valuation Allowance On Net Operating Loss Carryforwardsin Dollars
ChangeInValuationAllowanceOnNetOperatingLossCarryforwardsinDollars
-0.281 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
74000000 usd
CY2022 crtd Imediate Expensing Percentage
ImediateExpensingPercentage
1 pure
CY2022 crtd Immediate Expensing Provision Description
ImmediateExpensingProvisionDescription
Beginning January 1, 2023, the immediate expensing provision is phased down by 20% per year until it is completely phased out as of January 1, 2027.
CY2017Q4 us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
1 usd
CY2022 us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
1417782 usd
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
6946851 shares
CY2022Q4 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
1500000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1216008 shares
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2364250 usd
CY2022 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
16134193 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
3477062 usd
CY2022 crtd Total Proceeds
TotalProceeds
300000 usd
CY2022 dei Auditor Firm
AuditorFirmId
89
CY2022Q4 crtd Minority Investment In Business
MinorityInvestmentInBusiness
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
usd
CY2022 crtd Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.60
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.44
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12652470 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22035260 shares
CY2021 crtd Reserve For Obsolete Inventory
ReserveForObsoleteInventory
usd
CY2022 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2022 crtd Cash Paid For Minority Investment In Business
CashPaidForMinorityInvestmentInBusiness
usd
CY2022 crtd Cash Paid For Equity Method Investment
CashPaidForEquityMethodInvestment
usd
CY2021 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
usd
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
CY2021 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
usd
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 crtd Settlement Of Vendor Liabilities Reduction Of Rou Asset Related To Remeasurement Of Lease Liability
SettlementOfVendorLiabilitiesReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability
usd
CY2021 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2021 crtd Shares Issued With Debt
SharesIssuedWithDebt
usd
CY2021 crtd Operating Lease Liability1
OperatingLeaseLiability1
usd
CY2022 crtd Deferred Offering Cost
DeferredOfferingCost
usd
CY2022 crtd Reduction Of Rou Asset Related To Remeasurement Of Lease Liability
ReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001357671

Files In Submission

Name View Source Status
0001213900-23-030833-index-headers.html Edgar Link pending
0001213900-23-030833-index.html Edgar Link pending
0001213900-23-030833.txt Edgar Link pending
0001213900-23-030833-xbrl.zip Edgar Link pending
crtd-20221231.xsd Edgar Link pending
f10k2022ex23-1_creatdinc.htm Edgar Link pending
f10k2022ex31-1_creatdinc.htm Edgar Link pending
f10k2022ex31-2_creatdinc.htm Edgar Link pending
f10k2022ex32-1_creatdinc.htm Edgar Link pending
f10k2022ex32-2_creatdinc.htm Edgar Link pending
f10k2022ex4-1_creatdinc.htm Edgar Link pending
f10k2022_creatdinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
crtd-20221231_cal.xml Edgar Link unprocessable
crtd-20221231_def.xml Edgar Link unprocessable
crtd-20221231_pre.xml Edgar Link unprocessable
crtd-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10k2022_creatdinc_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending